These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 22155125

  • 1. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB.
    Mutat Res; 2012 Feb 18; 742(1-2):92-5. PubMed ID: 22155125
    [Abstract] [Full Text] [Related]

  • 2. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS.
    Urol Oncol; 2014 Feb 18; 32(2):214. PubMed ID: 24445298
    [Abstract] [Full Text] [Related]

  • 3. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.
    Cancer Res; 1998 Sep 01; 58(17):3806-11. PubMed ID: 9731488
    [Abstract] [Full Text] [Related]

  • 4. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC, Wang SC, Haque MM, Lin WH, Lin LC, Chen CH, Liu YW.
    PLoS One; 2017 Sep 01; 12(10):e0186214. PubMed ID: 29016672
    [Abstract] [Full Text] [Related]

  • 5. Review: BBN as an urothelial carcinogen.
    Vasconcelos-Nóbrega C, Colaço A, Lopes C, Oliveira PA.
    In Vivo; 2012 Sep 01; 26(4):727-39. PubMed ID: 22773588
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A, Ogawa K, Sugiura S, Asamoto M, Takeshita F, Sato SY, Nakanishi M, Kohri K, Shirai T.
    Int J Cancer; 2008 Mar 15; 122(6):1222-8. PubMed ID: 18027869
    [Abstract] [Full Text] [Related]

  • 7. Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
    Dunois-Lardé C, Levrel O, Brams A, Thiery JP, Radvanyi F.
    Mol Carcinog; 2005 Mar 15; 42(3):142-9. PubMed ID: 15690367
    [Abstract] [Full Text] [Related]

  • 8. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
    Lubet RA, Huebner K, Fong LY, Altieri DC, Steele VE, Kopelovich L, Kavanaugh C, Juliana MM, Soong SJ, Grubbs CJ.
    Carcinogenesis; 2005 Mar 15; 26(3):571-8. PubMed ID: 15591090
    [Abstract] [Full Text] [Related]

  • 9. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K, St John M, Luiza de Oliveira M, Arnold L, Shirai T, Sun TT, Cohen SM.
    Toxicol Pathol; 1999 Mar 15; 27(6):645-51. PubMed ID: 10588545
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.
    Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM.
    Carcinogenesis; 2008 Apr 15; 29(4):846-8. PubMed ID: 18192690
    [Abstract] [Full Text] [Related]

  • 12. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H.
    Carcinogenesis; 2000 Jul 15; 21(7):1391-6. PubMed ID: 10874018
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ, Thompson HJ, Grubbs CJ, Squire RA, Brown CC, Sporn MB, Moon RC.
    Cancer Res; 1978 Dec 15; 38(12):4463-6. PubMed ID: 719631
    [Abstract] [Full Text] [Related]

  • 14. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Sugie S, Vinh PQ, Rahman KM, Ushida J, Kohno H, Suzuki R, Hara A, Quang le B, Tanaka T, Mori H.
    Int J Cancer; 2005 Nov 20; 117(4):524-30. PubMed ID: 15929075
    [Abstract] [Full Text] [Related]

  • 15. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
    Tyagi A, Raina K, Singh RP, Gu M, Agarwal C, Harrison G, Glode LM, Agarwal R.
    Mol Cancer Ther; 2007 Dec 20; 6(12 Pt 1):3248-55. PubMed ID: 18089718
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
    Lubet RA, Fischer SM, Steele VE, Juliana MM, Desmond R, Grubbs CJ.
    Int J Cancer; 2008 Nov 15; 123(10):2254-9. PubMed ID: 18712722
    [Abstract] [Full Text] [Related]

  • 17. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
    Szende B, Jeney A, Institoris L.
    Acta Morphol Hung; 1992 Nov 15; 40(1-4):187-93. PubMed ID: 1365762
    [Abstract] [Full Text] [Related]

  • 18. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters.
    Hashimura T, Kanamaru H, Yoshida O.
    Jpn J Cancer Res; 1987 May 15; 78(5):473-9. PubMed ID: 3112059
    [Abstract] [Full Text] [Related]

  • 19. Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice.
    Lin PY, Lin YL, Huang CC, Chen SS, Liu YW.
    Toxicol Appl Pharmacol; 2012 Feb 15; 259(1):27-37. PubMed ID: 22178741
    [Abstract] [Full Text] [Related]

  • 20. Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide.
    Numoto S, Yoshida M, Otsuka H.
    Gan; 1981 Oct 15; 72(5):647-54. PubMed ID: 7327366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.